Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Determining a Company’s Value - Old School

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Apr 24, 2022 4:55am

195 Views

Post# 34626974

RE:RE:RE:RE:Determining a Company’s Value - Old School

It would be good to be confident that 'the tech is still on track' Rumpl but we had two scheduled Phase 1B Trials with Rutherrin and now there are none with one of those major indications (GBM) being entirely removed from the pipeline.

Also left wondering whether Roswell were denied consent to use TLD-1433 in NSCLC/mesothelioma or whether the drug itself didn`t make the cut?

Don`t feel anything like sufficiently informed to be able to make such an evaluation.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale